Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Advanced breast cancer: diagnosis and treatment (updated NICE guideline CG81)
Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumours (new NICE guideline TA1034)
Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (updated NICE guideline HTE12)
Durvalumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancer (new NICE guideline TA1030)
Durvalumab with etoposide and either carboplatin or cisplatin for untreated extensive-stage small-cell lung cancer (new NICE guideline TA1041)
Early and locally advanced breast cancer: diagnosis and management (updated NICE guideline NG101)
Elacestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation after endocrine treatment (new NICE guideline TA1036)
Home hospitalization in palliative care for advanced cancer and dementia: a systematic review
Imaging in diagnosis and active surveillance for prostate cancer: a review
Intratumoral administration of mRNA COVID-19 vaccine delays melanoma growth in mice
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced epithelial ovarian cancer (updated Cochrane intervention review)
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy (new NICE guideline TA1040)
Ovarian cancer (updated NICE guideline QS18)
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer (new NICE guideline TA1037)
Selpercatinib for advanced thyroid cancer with RET alterations after treatment with a targeted cancer drug in people 12 years and over (new NICE guideline TA1038)
Selpercatinib for advanced thyroid cancer with RET alterations untreated with a targeted cancer drug in people 12 years and over (new NICE guideline TA1039)
Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancer (new NICE guideline TA1042)
Tebentafusp for treating advanced uveal melanoma (new NICE guideline IPG798)
Cochrane Library (Jan-Feb); JAMA Surgery (Jan); Journal of Pain and Symptom Management (Mar); Lancet, The (Jan); NICE website (Jan-Feb); Scientific Reports (Feb)
Cancer chemotherapy: incidence and predictors of 30-day mortality
Cancer pain self-management interventions in adults: scoping review
Cancer treatment refusal decisions in advanced cancer: a retrospective case–control study
CAR T cells and T-cell therapies for cancer: a translational science review
Colorectal cancer survivors’ quality of life: a qualitative study of unmet need
Decision tree algorithm to predict mortality in incurable cancer: a new prognostic model
Did Michelangelo paint a young adult woman with breast cancer in “The Flood” (Sistine Chapel, Rome)?
Digital health for cancer symptom management in palliative medicine: systematic review
Introducing palliative care in advanced cancer: a systematic review
Medical cannabis use in young adults with cancer: a self-reported survey study
Oesophageal cancer (Lancet seminar)
Opioid initiation timing and palliative care referrals in advanced cancer: retrospective study
The optimal timing of breast cancer surgery after COVID-19 infection: an observational study
Paediatric relapsed acute leukaemia: curative intent chemotherapy improves quality of life
Pain management effectiveness in advanced cancer: palliative care unit inpatient study
Preoperative chemoradiotherapy for resectable gastric cancer
RNA-loaded nanoparticles for the treatment of hematological cancers
Thirty-day mortality in hospitalised patients with lung cancer: incidence and predictors
Advanced Drug Delivery Reviews (Nov); American Journal of Surgery, The (Nov); BMC Cancer (Nov); BMJ Supportive and Palliative Care (Nov-Dec); Breast, The (Dec); JAMA (Dec); Lancet, The (Nov); NEJM (Nov)
Belzutifan for treating tumours associated with von Hippel-Lindau disease (new NICE guideline TA1011)
Compassionate presence in seriously ill cancer patients
Early palliative care versus usual haematological care in multiple myeloma
Gabapentinoids for chemotherapy-induced peripheral neuropathy
Hairy-cell leukemia (NEJM review)
Implants versus autologous tissue flaps for breast reconstruction following mastectomy (new Cochrane intervention review)
Medical cannabis for refractory cancer-related pain in a specialised clinical service
Medical oncologist stereotypes among medical students, residents and physicians
Nonpharmacological intervention for delirium in patients with cancer: a scoping review
Nutritional status and primary tumour site in incurable cancer
Pediatric oncology hospice: a comprehensive review
Prioritising primary care patients with unexpected weight loss for cancer investigation (BMJ update)
Prostate cancer: unmet supportive and palliative care needs
Quizartinib for induction, consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukaemia (new NICE guideline TA1013)
Reductions in recurrence in women with early breast cancer entering clinical trials 1990-2009
Renal cell carcinoma (JAMA review)
Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer (new NICE guideline TA1007)
Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatments (new NICE guideline TA1008)
Zanubrutinib for treating marginal zone lymphoma after anti-CD20-based treatment (new NICE guideline TA1001)
American Journal of Hospice and Palliative Medicine (Dec); BMJ, The Oct); BMJ Supportive and Palliative Care (Sep); Cochrane Library (Sep-Oct); JAMA (Aug); Journal of Pain and Symptom Management (Nov); Lancet, The (Oct); NEJM (Oct); NICE website (Sep-Oct); Scandinavian Journal of Primary Health Care (Sep)
The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.